Expertise in
22
conditions

Helge Mollmann

St. Johannes Hospital Dortmund
Dortmund, NW, DE 
Clinical Trials:Currently Recruiting for 2 Trials
Expertise in
22
conditions
St. Johannes Hospital Dortmund
Dortmund, NW, DE 
OverviewLocationsClinical Research

Overview

Helge Mollmann practices in Dortmund, Germany. Mr. Mollmann is highly rated in 22 conditions, according to our data. His top areas of expertise are Aortic Valve Stenosis, Mitral Valve Regurgitation, Coronary Heart Disease, Transcatheter Aortic Valve Replacement (TAVR), and Aortic Valve Replacement.

His clinical research consists of co-authoring 352 peer reviewed articles and participating in 18 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Male

Locations

St. Johannes Hospital Dortmund
Dortmund, NW, Germany
Other Locations
Deutsches Herzzentrum der Charite
Berlin, BE, Germany
St. Vinzenz Hospital Cologne
Koeln, NW, Germany
Frankfurt Am Main, HE, Germany
Wuppertal, NW, Germany
Asklepios Klinik St. Georg, Lohmühlenstrasse 5, St. Georg, HH, Germany
Bad Nauheim, HE, Germany
Dresden, SN, Germany
Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

18 Clinical Trials

Transcatheter Repair of Mitral Regurgitation With Edwards PASCAL Transcatheter Valve Repair System: A European Prospective, Multicenter Post Market Clinical Follow-Up (PMCF)
Transcatheter Repair of Mitral Regurgitation With Edwards PASCAL Transcatheter Valve Repair System: A European Prospective, Multicenter Post Market Clinical Follow-Up (PMCF)
Enrollment Status: Recruiting
Publish Date: June 26, 2025
Intervention Type: Device
VANTAGE Clinical Trial Evaluation of TAVR Using the NAVITOR Valve in a Global Investigation
VANTAGE Clinical Trial Evaluation of TAVR Using the NAVITOR Valve in a Global Investigation
Enrollment Status: Recruiting
Publish Date: April 06, 2025
Intervention Type: Device
Study Phase: Not Applicable
Tiara™ Transcatheter Mitral Valve Replacement Study (TIARA-II)
Tiara™ Transcatheter Mitral Valve Replacement Study (TIARA-II)
Enrollment Status: Completed
Publish Date: September 29, 2025
Intervention Type: Device
Study Phase: Not Applicable
SMall Annuli Randomized To Evolut™ or SAPIEN™ Trial
SMall Annuli Randomized To Evolut™ or SAPIEN™ Trial
Enrollment Status: Active_not_recruiting
Publish Date: August 19, 2025
Intervention Type: Device
Study Phase: Not Applicable
A Post-Market Study Assessment of the Safety and Performance of the MitraClip G4 System
A Post-Market Study Assessment of the Safety and Performance of the MitraClip G4 System
Enrollment Status: Active_not_recruiting
Publish Date: July 11, 2025
Intervention Type: Device
Evaluation of a Sirolimus Eluting Bioadaptor as Compared to a Zotarolimus Eluting Stent in De Novo Native Coronary Arteries ELX-CL-1805
Evaluation of a Sirolimus Eluting Bioadaptor as Compared to a Zotarolimus Eluting Stent in De Novo Native Coronary Arteries ELX-CL-1805
Enrollment Status: Active_not_recruiting
Publish Date: March 24, 2025
Intervention Type: Device
Study Phase: Not Applicable
An Observational Real-world Study Evaluating Severe Tricuspid Regurgitation Patients Treated with the Abbott TriClip™ Device
An Observational Real-world Study Evaluating Severe Tricuspid Regurgitation Patients Treated with the Abbott TriClip™ Device
Enrollment Status: Active_not_recruiting
Publish Date: January 08, 2025
Intervention Type: Device
CONtrolled Delivery For ImproveD outcomEs With cliNiCal Evidence
CONtrolled Delivery For ImproveD outcomEs With cliNiCal Evidence
Enrollment Status: Completed
Publish Date: October 21, 2024
Intervention Type: Device
Study Phase: Not Applicable
Early Feasibility EXperience of Posterior Leaflet RestOration to REduce Mitral Regurgitation (EXPLORE MR)
Early Feasibility EXperience of Posterior Leaflet RestOration to REduce Mitral Regurgitation (EXPLORE MR)
Enrollment Status: Terminated
Publish Date: December 18, 2023
Transcatheter Repair of Tricuspid Regurgitation With Cardioband TR System Post-Market Clinical Follow-Up Study (TriBAND): A European Prospective, Multicenter Post-market Clinical Follow-up Study to Assess Transcatheter Tricuspid Valve Repair With Edwards Cardioband TR System in Patients With Symptomatic Chronic Functional Tricuspid Regurgitation.
Transcatheter Repair of Tricuspid Regurgitation With Cardioband TR System Post-Market Clinical Follow-Up Study (TriBAND): A European Prospective, Multicenter Post-market Clinical Follow-up Study to Assess Transcatheter Tricuspid Valve Repair With Edwards Cardioband TR System in Patients With Symptomatic Chronic Functional Tricuspid Regurgitation.
Enrollment Status: Active_not_recruiting
Publish Date: April 06, 2023
Intervention Type: Device
Prospective, Randomized Trial of Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndrome - Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment (ISAR-REACT) 5
Prospective, Randomized Trial of Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndrome - Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment (ISAR-REACT) 5
Enrollment Status: Completed
Publish Date: February 06, 2023
Intervention Type: Drug
Study Drugs: Ticagrelor, Prasugrel
Study Phase: Phase 4
German-Austrian Register to Evaluate the Short and Long-term Safety and Therapy Outcomes of the ABSORB Everolimus-eluting Bioresorbable Vascular Scaffold System in Patients With Coronary Artery Stenosis
German-Austrian Register to Evaluate the Short and Long-term Safety and Therapy Outcomes of the ABSORB Everolimus-eluting Bioresorbable Vascular Scaffold System in Patients With Coronary Artery Stenosis
Enrollment Status: Completed
Publish Date: April 01, 2022
Intervention Type: Device
RIVA-PCI Registry - Prospective Registry of Rivaroxaban in Patients With Atrial Fibrillation
RIVA-PCI Registry - Prospective Registry of Rivaroxaban in Patients With Atrial Fibrillation
Enrollment Status: Completed
Publish Date: March 31, 2022
A Study of Percutaneous Repair of Functional Mitral Regurgitation Using the Ancora Heart, Inc. AccuCinch® Ventricular Repair System - The CINCH-2 Study
A Study of Percutaneous Repair of Functional Mitral Regurgitation Using the Ancora Heart, Inc. AccuCinch® Ventricular Repair System - The CINCH-2 Study
Enrollment Status: Completed
Publish Date: July 29, 2021
Intervention Type: Device
Study Phase: Not Applicable
X-Pand is Intended to Use the DESolve Scaffold System in Treatment of CAD Patients, by Including Real World Use of the DESolve Scaffold Over a Broad Spectrum of Geographies, A Wide Variety of Practicing Clinicians & A Minimum Degree Of Selection Criteria
X-Pand is Intended to Use the DESolve Scaffold System in Treatment of CAD Patients, by Including Real World Use of the DESolve Scaffold Over a Broad Spectrum of Geographies, A Wide Variety of Practicing Clinicians & A Minimum Degree Of Selection Criteria
Enrollment Status: Terminated
Publish Date: April 26, 2021
Intervention Type: Device
Practical Evaluation of Fractional Flow Reserve (FFR) and Its Associated Alternate Indices During Routine Clinical Procedures
Practical Evaluation of Fractional Flow Reserve (FFR) and Its Associated Alternate Indices During Routine Clinical Procedures
Enrollment Status: Completed
Publish Date: February 07, 2020
Intervention Type: Device
The RELIEF Trial: REduction or eLimination of mItral rEgurgitation in Degenerative or Functional Mitral Regurgitation With the CardiAQ-Edwards™ Transcatheter Mitral Valve
The RELIEF Trial: REduction or eLimination of mItral rEgurgitation in Degenerative or Functional Mitral Regurgitation With the CardiAQ-Edwards™ Transcatheter Mitral Valve
Enrollment Status: Withdrawn
Publish Date: January 09, 2018
Intervention Type: Device
Study Phase: Phase 1/Phase 2
PARACHUTE V: PercutAneous Ventricular RestorAtion in Chronic Heart FailUre Due to Ischemic HearT DiseasE. A German Trial to Evaluate the Improvement in Quality of Life and Cardiac Output Following Implanting of the Parachute Implant System
PARACHUTE V: PercutAneous Ventricular RestorAtion in Chronic Heart FailUre Due to Ischemic HearT DiseasE. A German Trial to Evaluate the Improvement in Quality of Life and Cardiac Output Following Implanting of the Parachute Implant System
Enrollment Status: Terminated
Publish Date: June 22, 2017
Intervention Type: Device
View 16 Less Clinical Trials

352 Total Publications

Peri-interventional Anesthesia Strategies for Transcatheter Aortic Valve Implantation: A Multicenter, Randomized, Controlled, Non-inferiority Trial.
Peri-interventional Anesthesia Strategies for Transcatheter Aortic Valve Implantation: A Multicenter, Randomized, Controlled, Non-inferiority Trial.
Journal: Circulation
Published: August 29, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Mollmann's expertise for a condition
ConditionClose
View All 8 Distinguished Conditions
View All 12 Advanced Conditions
View All 25 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile